Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ACTRN12626001106325) titled 'Subcutaneous injections of benzathine penicillin G (SCIP) for rheumatic heart disease in Boorloo' on Sept. 8.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Non-randomised trial
Masking: Open (masking not used)
Assignment: Single group
Primary Sponsor: The Kids Research Institute Australia
Condition:
Rheumatic heart disease
Rheumatic fever
Rheumatic heart disease
Rheumatic fever
Cardiovascular - Other cardiovascular diseases
Infection - Other infectious diseases
Intervention:
Subcutaneous injections of benzathine penicillin G (termed 'SCIP') will be offered as an alternative t...